Published in Environ Health Perspect on May 05, 2010
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect (2010) 2.62
A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ Health (2014) 1.88
The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol (2012) 1.53
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol (2011) 1.42
Bisphenol A alters early oogenesis and follicle formation in the fetal ovary of the rhesus monkey. Proc Natl Acad Sci U S A (2012) 1.31
Comparison of serum bisphenol A concentrations in mice exposed to bisphenol A through the diet versus oral bolus exposure. Environ Health Perspect (2011) 1.19
Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol Cell Endocrinol (2014) 1.05
Bisphenol A exposure reduces the estradiol response to gonadotropin stimulation during in vitro fertilization. Fertil Steril (2011) 1.04
Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system. J Steroid Biochem Mol Biol (2011) 0.94
Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population. J Transl Med (2015) 0.93
A review of the carcinogenic potential of bisphenol A. Reprod Toxicol (2015) 0.92
The epigenetic lorax: gene-environment interactions in human health. Epigenomics (2012) 0.92
Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant rhesus monkeys: Relevance for human exposures. Reprod Toxicol (2014) 0.88
Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice. J Am Heart Assoc (2014) 0.83
Bisphenol a in chronic kidney disease. Int J Nephrol (2013) 0.82
Exposure to the BPA-Substitute Bisphenol S Causes Unique Alterations of Germline Function. PLoS Genet (2016) 0.82
Exposure to bisphenol A in Canada: invoking the precautionary principle. CMAJ (2011) 0.82
Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model. Gut Microbes (2016) 0.78
Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation. Int J Obes (Lond) (2016) 0.78
Novel functions of PXR in cardiometabolic disease. Biochim Biophys Acta (2016) 0.77
Changes in urinary bisphenol A concentrations associated with placement of dental composite restorations in children and adolescents. J Am Dent Assoc (2016) 0.77
Bisphenol A exposure enhances atherosclerosis in WHHL rabbits. PLoS One (2014) 0.76
Biomonitoring method for bisphenol A in human urine by ultra-high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2014) 0.76
Bisphenol A impairs hepatic glucose sensing in C57BL/6 male mice. PLoS One (2013) 0.76
Recent advances in simultaneous analysis of bisphenol A and its conjugates in human matrices: Exposure biomarker perspectives. Sci Total Environ (2016) 0.75
Anatomical specificity of the brain in the modulation of Neuroglobin and Cytoglobin genes after chronic bisphenol a exposure. Metab Brain Dis (2017) 0.75
Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect (2008) 8.60
Human exposure to bisphenol A (BPA). Reprod Toxicol (2007) 6.91
Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect (2010) 5.19
In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol (2007) 4.97
Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect (2005) 4.93
Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol (2002) 4.52
Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology (2006) 4.22
Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol (2007) 4.04
Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev (2008) 4.03
In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol (2007) 3.69
Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect (2009) 3.30
Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect (2008) 3.27
Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect (2008) 3.17
NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. NTP CERHR MON (2008) 3.02
Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem (2005) 1.98
An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol (2007) 1.83
An ecological assessment of bisphenol-A: evidence from comparative biology. Reprod Toxicol (2007) 1.80
Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels. Environ Res (2009) 1.67
Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.65
Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect (2003) 1.62
Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab Dispos (2005) 1.60
GerES IV: phthalate metabolites and bisphenol A in urine of German children. Int J Hyg Environ Health (2009) 1.57
Gender differences in the levels of bisphenol A metabolites in urine. Biochem Biophys Res Commun (2003) 1.46
Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ Health Perspect (2010) 1.32
Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model. Environ Health Perspect (2008) 1.29
Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol (2010) 1.24
Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol Lett (2008) 1.17
Measurement of bisphenol A levels in human urine. J Expo Anal Environ Epidemiol (2001) 1.15
Bisphenol A levels in blood depend on age and exposure. Toxicol Lett (2009) 1.06
Bisphenol a workshop of the german federal environment agency - march 30-31, 2009 work group report: public health issues of bisphenol a. Int J Hyg Environ Health (2009) 0.94
A CASCADE of effects of bisphenol A. Reprod Toxicol (2009) 0.88
Sample clean-up with sol-gel enzyme and immunoaffinity columns for the determination of bisphenol A in human urine. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.87
Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect (2002) 5.24
Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect (2010) 5.19
Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect (2008) 3.27
A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ Health (2014) 1.88
Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology (2003) 1.87
Developmental exposure to low dose PBDE 99: effects on male fertility and neurobehavior in rat offspring. Environ Health Perspect (2005) 1.63
Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect (2014) 1.61
Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord (2007) 1.61
Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep. Biol Reprod (2012) 1.51
Sensitivity and specificity of pulse detection using a new deconvolution method. Am J Physiol Endocrinol Metab (2009) 1.49
A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl)-phthalate (DEHP): non-monotonic dose-response and low dose effects on rat brain aromatase activity. Toxicology (2006) 1.36
Bisphenol A and chronic disease risk factors in US children. Pediatrics (2013) 1.35
The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep. Endocrinology (2009) 1.35
Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology (2005) 1.34
Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Cien Saude Colet (2012) 1.30
Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinology (2006) 1.26
Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab (2005) 1.25
Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology (2007) 1.24
Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology (2005) 1.23
Developmental exposure to low-dose PBDE-99: tissue distribution and thyroid hormone levels. Toxicology (2007) 1.22
Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology (2003) 1.20
Fetal programming: prenatal androgen disrupts positive feedback actions of estradiol but does not affect timing of puberty in female sheep. Biol Reprod (2002) 1.18
Hypertension caused by prenatal testosterone excess in female sheep. Am J Physiol Endocrinol Metab (2007) 1.15
Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biol Reprod (2010) 1.15
Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology (2005) 1.13
In utero and lactational exposures to low doses of polybrominated diphenyl ether-47 alter the reproductive system and thyroid gland of female rat offspring. Environ Health Perspect (2008) 1.12
Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod (2008) 1.10
Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol Reprod (2008) 1.09
Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep. Biol Reprod (2007) 1.04
Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep. Biol Reprod (2009) 1.04
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril (2012) 1.04
Ultrastructural changes observed in rat ovaries following in utero and lactational exposure to low doses of a polybrominated flame retardant. Toxicol Lett (2005) 1.03
A dose response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult male offspring rats. Toxicology (2006) 1.03
Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity--implication for polycystic ovary syndrome. Endocrinology (2008) 1.02
Reproductive toxicity of phthalate esters. Mol Nutr Food Res (2010) 1.02
Contributions of androgen and estrogen to fetal programming of ovarian dysfunction. Reprod Biol Endocrinol (2006) 1.01
Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction (2009) 1.00
Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci (2010) 0.99
Polycystic ovary syndrome and oocyte developmental competence. Obstet Gynecol Surv (2008) 0.98
Programming of GnRH feedback controls timing puberty and adult reproductive activity. Mol Cell Endocrinol (2006) 0.98
Prenatal testosterone excess reduces sperm count and motility. Endocrinology (2008) 0.97
Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol Reprod (2010) 0.95
Prenatal exposure to excess testosterone modifies the developmental trajectory of the insulin-like growth factor system in female sheep. J Physiol (2006) 0.95
Fetal programming: testosterone exposure of the female sheep during midgestation disrupts the dynamics of its adult gonadotropin secretion during the periovulatory period. Biol Reprod (2004) 0.95
Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause (2008) 0.95
A dose-response study following in utero and lactational exposure to di(2-ethylhexyl)phthalate: effects on female rat reproductive development. Toxicol Sci (2006) 0.94
Plasmodium berghei (ANKA): infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver. Exp Parasitol (2006) 0.93
Prenatal exposure of the ovine fetus to androgens sexually differentiates the steroid feedback mechanisms that control gonadotropin releasing hormone secretion and disrupts ovarian cycles. Arch Sex Behav (2002) 0.93
Differential effects of prenatal testosterone timing and duration on phenotypic and behavioral masculinization and defeminization of female sheep. Biol Reprod (2008) 0.93
Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus. Toxicol Appl Pharmacol (2010) 0.93
Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression. Endocrinology (2013) 0.92
Prenatal testosterone and dihydrotestosterone exposure disrupts ovine testicular development. Reproduction (2011) 0.92
A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult female offspring rats. Toxicology (2006) 0.92
A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): effects on androgenic status, developmental landmarks and testicular histology in male offspring rats. Toxicology (2006) 0.91
Prepubertal administration of estradiol valerate disrupts cyclicity and leads to cystic ovarian morphology during adult life in the rat: role of sympathetic innervation. Endocrinology (2003) 0.91
Comparative toxicity of Euphorbia milii latex and synthetic molluscicides to Biomphalaria glabrata embryos. Chemosphere (2010) 0.90
Insight into the neuroendocrine site and cellular mechanism by which cortisol suppresses pituitary responsiveness to gonadotropin-releasing hormone. Endocrinology (2007) 0.90
Delivery type not associated with global methylation at birth. Clin Epigenetics (2012) 0.90
Developmental effects of prenatal exposure to bisphenol a on the uterus of rat offspring. Neoplasia (2004) 0.90
Chemical composition, toxicity and mosquito repellency of Ocimum selloi oil. J Ethnopharmacol (2003) 0.89
Prenatal testosterone treatment alters LH and testosterone responsiveness to GnRH agonist in male sheep. Biol Res (2008) 0.89
Developmental programming: gestational testosterone treatment alters fetal ovarian gene expression. Endocrinology (2011) 0.89
In utero exposure to low-dose 2,3',4,4',5-pentachlorobiphenyl (PCB 118) impairs male fertility and alters neurobehavior in rat offspring. Toxicology (2004) 0.88
Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere (2013) 0.88
Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep. Endocrinology (2010) 0.87
GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A. Hum Reprod (2004) 0.87
Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles. Fertil Steril (2012) 0.87
Expression of mRNA for galanin, galanin-like peptide and galanin receptors 1-3 in the ovine hypothalamus and pituitary gland: effects of age and gender. Reproduction (2008) 0.87
Long-term exposure of female sheep to physiologic concentrations of estradiol: effects on the onset and maintenance of reproductive function, pregnancy, and social development in female offspring. Biol Reprod (2006) 0.86
Biological and tumor-promoting effects of dioxin-like and non-dioxin-like polychlorinated biphenyls in mouse liver after single or combined treatment. Toxicol Sci (2013) 0.85
Thalidomide embryopathy cases in Brazil after 1965. Reprod Toxicol (2006) 0.85
Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues. Endocrinology (2010) 0.84
Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic. Endocrinology (2002) 0.84
Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition. Fertil Steril (2007) 0.83
Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models. Malar J (2010) 0.83
2-Bromopropane induces DNA damage, impairs functional antioxidant cellular defenses, and enhances the lipid peroxidation process in primary cultures of rat Leydig cells. Reprod Toxicol (2002) 0.83
Intrauterine bisphenol A exposure leads to stimulatory effects on Sertoli cell number in rats. Environ Res (2003) 0.83
Environment and origin of disease. Rev Endocr Metab Disord (2007) 0.83
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. PLoS One (2010) 0.83
Effect of low dose mono-ortho 2,3',4,4',5 pentachlorobiphenyl on thyroid hormone status and EROD activity in rat offspring: consequences for risk assessment. Toxicology (2003) 0.83
Developmental programming: postnatal steroids complete prenatal steroid actions to differentially organize the GnRH surge mechanism and reproductive behavior in female sheep. Endocrinology (2013) 0.83
Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep. Endocrinology (2012) 0.82
Impact of gestational bisphenol A on oxidative stress and free fatty acids: Human association and interspecies animal testing studies. Endocrinology (2015) 0.82
Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets. Toxicol Appl Pharmacol (2004) 0.82
Assessment of sensitization potential of monoterpenes using the rat popliteal lymph node assay. Food Chem Toxicol (2007) 0.82
Influence of litter size on the postnatal growth of rat pups: is there a rationale for litter-size standardization in toxicity studies? Environ Res (2009) 0.82
Polycystic ovary syndrome--"A riddle wrapped in a mystery inside an enigma". J Clin Endocrinol Metab (2009) 0.82
Developmental toxicity of copaiba tree (Copaifera reticulata Ducke, Fabaceae) oleoresin in rat. Food Chem Toxicol (2011) 0.81
In utero programming of sexually differentiated gonadotrophin releasing hormone (GnRH) secretion. Domest Anim Endocrinol (2002) 0.81
Diurnal changes in FSH-regulatory peptides and their relationship to gonadotrophins in pubertal girls. Hum Reprod (2004) 0.81
Developmental programming: exogenous gonadotropin treatment rescues ovulatory function but does not completely normalize ovarian function in sheep treated prenatally with testosterone. Biol Reprod (2008) 0.81